首页 > 市场调查报告书 > 医疗设备

药物递输设备

疫苗输送装置市场规模、份额和成长分析（按装置、给药途径、最终用户和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1900062

疫苗输送装置市场规模、份额和成长分析（按装置、给药途径、最终用户和地区划分）－2026-2033年产业预测

Vaccine Delivery Devices Market Size, Share, and Growth Analysis, By Type of Device (Needle-Free Injection Systems, Oral Delivery Systems), By Route of Administration, By End Users, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月26日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，疫苗输送设备市场规模将达到 73.3 亿美元，到 2025 年将达到 79.4 亿美元，到 2033 年将达到 150.2 亿美元，在预测期（2026-2033 年）内，复合年增长率为 8.3%。

疫苗接种活动的增加以及对高效接种解决方案的需求推动了疫苗接种器材市场强劲成长。主要驱动因素包括疫苗接种计划的扩展、针头技术的进步以及预防医学意识的提高。在储存和运输过程中，尤其是在低温运输物流方面，维持疫苗品质是关注的重点。接种器材的创新旨在确保疫苗的妥善储存，尤其是在冷藏设施有限的地区。温度稳定的配方和包装的开发提高了偏远地区疫苗的可及性。此外，自毁式註射器、安全针头和预填充系统的广泛应用有助于安全且准确地接种疫苗。虽然北美和欧洲目前占据市场主导地位，但亚太地区展现出巨大的成长潜力，凸显了对创新且经济高效的解决方案的需求。

疫苗接种设备市场驱动因素

感染疾病流行，导致疫苗需求显着增长，这主要得益于旨在根除可预防疾病的全球卫生倡议。疫苗需求的成长凸显了开发高效能疫苗接种装置的重要性，这些装置在促进适当免疫方面发挥关键作用。随着医疗机构努力提高疫苗接种率并改善公共卫生状况，对创新可靠的接种机制的关注变得至关重要。因此，由于需要改善全球人口的疫苗接种方式，疫苗接种装置市场正经历需求激增。

疫苗接种设备市场的限制

创新疫苗接种设备的研发和生产通常需要大量的研发投入。这些成本最终可能会转嫁给最终用户，例如医疗服务提供者和患者，并可能阻碍这些设备的广泛应用，尤其是在资源匮乏的地区。这种经济负担可能会使医疗机构不愿采用先进技术，从而限制了有效疫苗接种方案的普及，并阻碍了旨在提高疫苗接种率的公共卫生措施的进展。因此，在某些地区，这些尖端设备的潜在益处可能无法充分发挥。

疫苗接种设备市场趋势

疫苗接种设备市场正经历着向无针接种系统创新发展的显着转变，旨在提高患者的舒适度和依从性。诸如喷射注射器、微针贴片和鼻喷剂等替代接种方式的兴起，旨在解决患者对针头的恐惧，同时简化疫苗接种流程。这些先进技术不仅最大限度地降低了针刺伤的风险，而且有望提高疫苗的稳定性和有效性。随着医疗机构致力于改善整体疫苗接种体验并扩大疫苗覆盖范围，市场对这些创新解决方案的需求持续增长，这代表着市场正在发生变革性变化。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Becton Dickinson & Company（USA）
Bioject Medical Technologies, Inc.（USA）
Inovio Pharmaceuticals, Inc.（USA）
PharmaJet（USA）
Vaxxas（Australia）
Gerresheimer AG（Germany）
SCHOTT AG（Germany）
Corium International, Inc.（USA）
3M（USA）
West Pharmaceutical Services, Inc.（USA）
Terumo Corporation（Japan）
B. Braun Melsungen AG（Germany）
Smiths Medical（UK）
Medtronic（Ireland）
Sanofi Pasteur（France）
Novartis AG（Switzerland）
Pfizer Inc.（USA）
GlaxoSmithKline plc（UK）
Merck & Co., Inc.（USA）
Johnson & Johnson（USA）

结论与建议

简介目录

Product Code: SQMIG35B2152

Vaccine Delivery Devices Market size was valued at USD 7.33 Billion in 2024 and is poised to grow from USD 7.94 Billion in 2025 to USD 15.02 Billion by 2033, growing at a CAGR of 8.3% during the forecast period (2026-2033).

The vaccine delivery devices market is experiencing robust growth driven by heightened vaccination initiatives and the demand for effective administration solutions. Key catalysts include the expansion of immunization programs, advancements in needle technologies, and a growing awareness of preventive healthcare. Maintaining vaccine integrity during storage and transport, particularly through cold chain logistics, is a critical focus area. Innovations in delivery devices are designed to ensure proper conditions for vaccines, especially in areas with limited refrigeration access. Developments in temperature-stable formulations and packaging enhance vaccine availability in remote regions. Additionally, the rise of auto-disable syringes, safety needles, and prefilled systems promotes safe and accurate delivery. While North America and Europe lead the market, Asia-Pacific shows significant growth potential, emphasizing the need for innovative and cost-effective solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Vaccine Delivery Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Vaccine Delivery Devices Market Segments Analysis

Global Vaccine Delivery Devices Market is segmented by Type of Device, Route of Administration, End Users and region. Based on Type of Device, the market is segmented into Needle-Free Injection Systems, Oral Delivery Systems, Nasal Delivery Systems, Jet Injectors, Microneedle Patches and Microinjectors. Based on Route of Administration, the market is segmented into Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination and Other Vaccinations. Based on End Users, the market is segmented into Hospitals, Clinics and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Vaccine Delivery Devices Market

The increasing prevalence of infectious diseases has significantly amplified the demand for vaccines, particularly in the context of global health initiatives aimed at eradicating preventable illnesses. This growing need for vaccinations underscores the importance of developing efficient and effective vaccine delivery devices, which play a crucial role in facilitating proper immunization. As healthcare providers strive to enhance vaccination rates and improve public health outcomes, the focus on innovative and reliable delivery mechanisms becomes paramount. Consequently, the Vaccine Delivery Devices market is experiencing a surge in demand, driven by the necessity for improved methods of administering vaccines to populations worldwide.

Restraints in the Vaccine Delivery Devices Market

The development and production of innovative vaccine delivery devices often require significant investment in research and development. Such expenses may ultimately be transferred to end-users, such as healthcare providers and patients, which could hinder the broader acceptance and utilization of these devices, especially in areas with limited resources. This financial burden may discourage healthcare facilities from adopting advanced technologies, restricting access to effective immunization solutions and impeding progress in public health initiatives aimed at improving vaccination rates. As a result, the potential benefits of these cutting-edge devices may not be fully realized in certain regions.

Market Trends of the Vaccine Delivery Devices Market

The Vaccine Delivery Devices market is experiencing a notable shift towards innovations in needle-free delivery systems, which are increasingly being embraced to enhance patient comfort and compliance. The rise of alternative delivery methods, including jet injectors, microneedle patches, and nasal sprays, is addressing concerns related to needle aversion while aiming to streamline vaccination processes. These advanced technologies not only minimize the risk of needle-stick injuries but also promise improved vaccine stability and efficacy. As healthcare providers focus on enhancing the overall vaccination experience and increasing accessibility, the demand for these innovative solutions continues to grow, signaling a transformative trend in the market.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape
Patent Analysis
Technology Analysis

Global Vaccine Delivery Devices Market Size by Type of Device & CAGR (2026-2033)

Market Overview
Needle-Free Injection Systems
Oral Delivery Systems
Nasal Delivery Systems
Jet Injectors
Microneedle Patches
Microinjectors

Global Vaccine Delivery Devices Market Size by Route of Administration & CAGR (2026-2033)

Market Overview
Intradermal Vaccination
Intramuscular Vaccination
Subcutaneous Vaccination
Other Vaccinations

Global Vaccine Delivery Devices Market Size by End Users & CAGR (2026-2033)

Market Overview
Hospitals
Clinics
Other End Users

Global Vaccine Delivery Devices Market Size & CAGR (2026-2033)

North America (Type of Device, Route of Administration, End Users)
- US
- Canada
Europe (Type of Device, Route of Administration, End Users)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type of Device, Route of Administration, End Users)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type of Device, Route of Administration, End Users)
- Brazil
- Rest of Latin America
Middle East & Africa (Type of Device, Route of Administration, End Users)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Becton Dickinson & Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioject Medical Technologies, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Inovio Pharmaceuticals, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PharmaJet (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vaxxas (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gerresheimer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SCHOTT AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Corium International, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
3M (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
West Pharmaceutical Services, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smiths Medical (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi Pasteur (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments